BARTON JACQUELINE K
SEC CIK 1183680 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GILD | Gilead Sciences | Dir | 27.2K | — | — | 6 | 2022-05-03 | 2026-04-30 |
Most active insiders at GILD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Day Daniel Patrick | COB, CEO, Dir | — | $51.34M |
| 2 | Mercier Johanna | Chief Commercial Off | — | $18.52M |
| 3 | Telman Deborah H | EVP, GC, Corp. Affairs | — | $6.59M |
| 4 | Dickinson Andrew D | CFO | — | $4.68M |
| 5 | WELTERS ANTHONY | Dir | — | $2.68M |
| 6 | Bluestone Jeffrey | Dir | — | $1.97M |
| 7 | Kramer Kelly A. | Dir | — | $713.2K |
| 8 | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | — | — |
| 9 | Burkhart Erin | SVP, Controllership | — | — |
| 10 | Berger Dietmar | Chief Medical Off | — | — |
| 15 | BARTON JACQUELINE K | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-04 16:36 | 2026-04-30 | GILD | Gilead Sciences | BARTON JACQUELINE K | Dir | A - Grant | $0.00 | +1,146 | 27.2K | +4% | $0 |
| D | 2025-05-08 | 2025-05-07 | GILD | Gilead Sciences | BARTON JACQUELINE K | Dir | A - Grant | $0.00 | +1,516 | 26.1K | +6% | $0 |
| D | 2024-05-09 | 2024-05-08 | GILD | Gilead Sciences | BARTON JACQUELINE K | Dir | A - Grant | $0.00 | +2,310 | 24.5K | +10% | $0 |
| D | 2023-05-04 | 2023-05-03 | GILD | Gilead Sciences | BARTON JACQUELINE K | Dir | A - Grant | $0.00 | +1,887 | 22.2K | +9% | $0 |
| D | 2022-05-06 | 2022-05-05 | GILD | Gilead Sciences | BARTON JACQUELINE K | Dir | A - Grant | $0.00 | +2,444 | 20.3K | +14% | $0 |
| D | 2022-05-03 | 2022-05-03 | GILD | Gilead Sciences | BARTON JACQUELINE K | Dir | M - OptEx | — | +2,223 | 17.9K | +14% | — |
Purchase Sale Sale after option exercise All abbreviations